CVS Health Co. (NYSE:CVS) Shares Sold by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. trimmed its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 6.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 474,900 shares of the pharmacy operator's stock after selling 31,000 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in CVS Health were worth $32,174,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Stonebridge Financial Group LLC acquired a new stake in shares of CVS Health during the 4th quarter worth $28,000. Hopwood Financial Services Inc. acquired a new stake in CVS Health in the 4th quarter valued at $29,000. McIlrath & Eck LLC increased its holdings in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 174 shares in the last quarter. MV Capital Management Inc. increased its holdings in CVS Health by 63.9% in the 1st quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock valued at $50,000 after purchasing an additional 289 shares in the last quarter. Finally, Financial Perspectives Inc increased its holdings in CVS Health by 137.5% in the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after purchasing an additional 466 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on CVS shares. Royal Bank of Canada increased their price target on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a report on Monday, May 5th. Cowen reiterated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Wells Fargo & Company reiterated an "overweight" rating and issued a $84.00 price target (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Morgan Stanley reissued an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Finally, Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $74.75.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the purchase, the director now directly owns 12,007 shares in the company, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 1.22% of the stock is owned by company insiders.

CVS Health Stock Up 1.6%

Shares of CVS stock traded up $1.07 during trading hours on Friday, hitting $67.42. 7,560,954 shares of the company were exchanged, compared to its average volume of 10,978,755. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a one year low of $43.56 and a one year high of $72.51. The business's 50-day simple moving average is $65.15 and its two-hundred day simple moving average is $60.15. The stock has a market capitalization of $85.29 billion, a price-to-earnings ratio of 18.42, a P/E/G ratio of 0.98 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. CVS Health's quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.31 earnings per share. Sell-side analysts predict that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 3.95%. CVS Health's dividend payout ratio (DPR) is 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.